期刊文献+

Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury 被引量:2

Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury
下载PDF
导出
摘要 AIM: To test whether hepatic stellate cells(HSCs) at different activation stages play different roles in acetaminophen(APAP)-induced acute liver injury(ALI).METHODS: HSCs were isolated from mouse liver and cultured in vitro.Morphological changes of initiation HSCs [HSCs(5d)] and perpetuation HSCs [HSCs(p3)] were observed by immunofluorescence and transmission electron microscopy.The protective effects of HSCderived molecules, cell lysates and HSC-conditioned medium(HSC-CM) were tested in vivo by survival and histopathological analyses.Liver injury was determined by measuring aminotransferase levels in the serum and by histologic examination of tissue sections under a light microscope.Additionally, to determine the molecular mediators of the observed protective effects of initiation HSCs, we examined HSC-CM using a highdensity protein array.RESULTS: HSCs(5d) and HSCs(p3) had different morphological and phenotypic traits.HSCs(5d) presented a star-shaped appearance with expressing α-SMA at non-uniform levels between cells.However, HSCs(p3) evolved into myofibroblast-like cells without lipid droplets and expressed a uniform and higher level of α-SMA.HSC-CM(5d), but not HSC-CM(p3), provided a significant survival benefit and showed a dramatic reduction of hepatocellular necrosis and panlobular leukocyte infiltrates in mice exposed to APAP.However, this protective effect was abrogated at higher cell masses, indicating a therapeutic window of effectiveness.Furthermore, the protein array screenrevealed that HSC-CM(5d) was composed of many chemokines and growth factors that correlated with inflammatory inhibition and therapeutic activity.When compared with HSC-CM(p3), higher levels of monocyte chemoattractant protein-1, macrophage inflammatory protein-1γ, hepatocyte growth factor, interleukin-10, and matrix metalloproteinase-2, but lower levels of stem cell factor and Fas-Ligand were observed in HSCCM(5d).CONCLUSION: These data indicated that initiation HSCs and perpetuation HSCs were different in morphology and protein expression, and provided the first experimental evidence of the potential medical value of initiation HSC-derived molecules in the treatment of ALI. AIM: To test whether hepatic stellate cells(HSCs) at different activation stages play different roles in acetaminophen(APAP)-induced acute liver injury(ALI).METHODS: HSCs were isolated from mouse liver and cultured in vitro.Morphological changes of initiation HSCs [HSCs(5d)] and perpetuation HSCs [HSCs(p3)] were observed by immunofluorescence and transmission electron microscopy.The protective effects of HSCderived molecules, cell lysates and HSC-conditioned medium(HSC-CM) were tested in vivo by survival and histopathological analyses.Liver injury was determined by measuring aminotransferase levels in the serum and by histologic examination of tissue sections under a light microscope.Additionally, to determine the molecular mediators of the observed protective effects of initiation HSCs, we examined HSC-CM using a highdensity protein array.RESULTS: HSCs(5d) and HSCs(p3) had different morphological and phenotypic traits.HSCs(5d) presented a star-shaped appearance with expressing α-SMA at non-uniform levels between cells.However, HSCs(p3) evolved into myofibroblast-like cells without lipid droplets and expressed a uniform and higher level of α-SMA.HSC-CM(5d), but not HSC-CM(p3), provided a significant survival benefit and showed a dramatic reduction of hepatocellular necrosis and panlobular leukocyte infiltrates in mice exposed to APAP.However, this protective effect was abrogated at higher cell masses, indicating a therapeutic window of effectiveness.Furthermore, the protein array screenrevealed that HSC-CM(5d) was composed of many chemokines and growth factors that correlated with inflammatory inhibition and therapeutic activity.When compared with HSC-CM(p3), higher levels of monocyte chemoattractant protein-1, macrophage inflammatory protein-1γ, hepatocyte growth factor, interleukin-10, and matrix metalloproteinase-2, but lower levels of stem cell factor and Fas-Ligand were observed in HSCCM(5d).CONCLUSION: These data indicated that initiation HSCs and perpetuation HSCs were different in morphology and protein expression, and provided the first experimental evidence of the potential medical value of initiation HSC-derived molecules in the treatment of ALI.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第14期4184-4194,共11页 世界胃肠病学杂志(英文版)
基金 Supported by Doctoral Fund of the Ministry of Education,No.2013007110041 Young Investigator Funding of Zhongshan Hospital,No.2014ZSQN37
关键词 HEPATIC stellate cells Acute liver INJURY Initiati Hepatic stellate cells Acute liver injury Initiati
  • 相关文献

参考文献20

  • 1Yin, Chunyue,Evason, Kimberley J,Asahina, Kinji,Stainier, Didier Y R.Hepatic stellate cells in liver development, regeneration, and cancer[J]. Journal of Clinical Investigation . 2013 (5)
  • 2P.-C. Shen,C.-L. Wu,I.-M. Jou,C.-H. Lee,H.-Y. Juan,P.-J. Lee,S.-H. Chen,J.-L. Hsieh.T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ[J]. Osteoarthritis and Cartilage . 2011 (6)
  • 3S.Padrissa‐Altés,M. A.Zaouali,R.Franco‐Gou,R.Bartrons,O.Boillot,A.Rimola,V.Arroyo,J.Rodés,C.Peralta,J.Roselló‐Catafau.Matrix Metalloproteinase 2 in Reduced‐Size Liver Transplantation: Beyond the Matrix[J]. American Journal of Transplantation . 2010 (5)
  • 4Anna Rutherford,Raymond Chung.Acute Liver Failure: Mechanisms of Hepatocyte Injury and Regeneration[J]. Semin Liver Dis . 2008 (02)
  • 5IL-10 Attenuates Hepatic I/R Injury and Promotes Hepatocyte Proliferation[J]. Journal of Surgical Research . 2007 (2)
  • 6Tania Roskams.Different types of liver progenitor cells and their niches[J]. Journal of Hepatology . 2006 (1)
  • 7XiaoyingZhou,Christopher J.Hovell,SusannahPawley,Matthew I.Hutchings,Michael J. P.Arthur,John P.Iredale,R. ChristopherBenyon.Expression of matrix metalloproteinase‐2 and ‐14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis[J]. Liver International . 2004 (5)
  • 8Charles Balabaud,Paulette Bioulac-Sage,Alexis Desmoulière.The role of hepatic stellate cells in liver regeneration[J]. Journal of Hepatology . 2004 (6)
  • 9Ayako Mabuchi,Ian Mullaney,Philip W Sheard,Paul A Hessian,Beth L Mallard,Michael N Tawadrous,Arthur Zimmermann,Haruki Senoo,Antony M Wheatley.Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat[J]. Journal of Hepatology . 2004 (6)
  • 10Vladimir V. Kalinichenko,Dibyendu Bhattacharyya,Yan Zhou,Galina A. Gusarova,Wooram Kim,Brian Shin,Robert H. Costa.Foxf1 +/? mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl 4 injury[J]. Hepatology . 2003 (1)

二级参考文献30

  • 1Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA and Stolz DB, et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006, 44:1171 - 1181.
  • 2Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ and Lu L, et al. Inhibition of T-cell responses by hepatic stellate cells via B7-Hl-mediated T-cell apoptosis in mice. Hepatology 2004, 40: 1312-1321.
  • 3Kupfahl C, Geginat G and Hof H. Gliotoxin-mediated suppression of innate and adaptive immune functions directed against Listeria monocytogenes. Med Mycol 2006, 44: 591-599.
  • 4Passino MA, Adams RA, Sikorski SL and Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007, 315: 1853-1856.
  • 5Ankoma-Sey V. Hepatic regeneration-revisiting the myth of prometheus. News Physiol Sci 1999, 14: 149-155.
  • 6Overturf K, Al-Dhalimy M, Finegold M and Grompe M. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol 1999, 155: 2135-2143.
  • 7Dabeva MD and Shafritz DA. Hepatic stem cells and liver repopulation. Semin Liver Dis 2003, 23: 349-362.
  • 8Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E and Theise ND. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 2008, 47: 1994-2002.
  • 9Zhang L, Theise N, Chua M and Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 2008, 48: 1598-1607.
  • 10Chun L J, Tong M J, Busuttil RW and Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009, 43: 342-349.

共引文献18

同被引文献14

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部